Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Assisted Reproduction and Genetics
Erschienen in: Journal of Assisted Reproduction and Genetics 12/2018

15.09.2018 | Review

Connecting links between genetic factors defining ovarian reserve and recurrent miscarriages

verfasst von: Deepika Delsa Dean, Sarita Agarwal, Poonam Tripathi

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Approximately 1–2% of the women faces three or more successive spontaneous miscarriages termed as recurrent miscarriage (RM). Many clinical factors have been attributed so far to be the potential risk factors in RM, including uterine anomalies, antiphospholipid syndrome, endocrinological abnormalities, chromosomal abnormalities, and infections. However, in spite of extensive studies, reviews, and array of causes known to be associated with RM, about 50% cases encountered by treating physicians remains unknown. The aims of this study were to evaluate recent publications and to explore oocyte-specific genetic factors that may have role in incidence of recurrent miscarriages.

Method

Recent studies have identified common molecular factors contributing both in establishment of ovarian reserve and in early embryonic development. Also, studies have pointed out the relationship between the age-associated depletion of OR and increase in the risk of miscarriages, thus suggestive of an interacting biology. Here, we have gathered literature evidences in establishing connecting links between genetic factors associated with age induced or pathological OR depletion and idiopathic RM, which are the two extreme ends of female reproductive pathology.

Conclusion

In light of connecting etiological link between infertility and RM as reviewed in this study, interrogating the oocyte-specific genes with suspected roles in reproductive biology, in cases of unexplained RM, may open new possibilities in widening our understanding of RM pathophysiology.
Literatur
1.
Royal College of Obstetricians and Gynaecologists (RCOG). The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. Green-top Guideline No. 17. Royal College of Obstetricians and Gynaecologists (RCOG), 2011.
2.
Coulam CB. Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol. 1991;26:23–7.PubMed
3.
Royal College of Obstetricians and Gynaecologists, Scientific Advisory Committee, Guideline No. 17. The Investigation and treatment of couples with recurrent miscarriage. 2011.
4.
Macklon NS, Geraedts JP, Fauser BC. Conception to ongoing pregnancy: the 'black box' of early pregnancy loss. Hum Reprod Update. 2002;8(4):333–43.PubMed
5.
McNamee K, Dawood F, Farquharson R. Recurrent miscarriage and thrombophilia: an update. Curr Opin Obstet Gynecol. 2012;24:229–34.PubMed
6.
Duckitt K, Qureshi A. Recurrent miscarriage. Clin Evid. 2011;2:1409.
7.
American College of Obstetrics and Gynecologists Committee on Practice Bulletins: ACOG Practice Bulletin. Paper 40. Obstet Gynecol 2011.
8.
Cohn DM, Goddijn M, Middeldorp S, et al. Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. J Thromb Haemost. 2010;8:2208–13.PubMed
9.
Patel BG, Lessey BA. Clinical assessment and management of the endometrium in recurrent early pregnancy loss. Semin Reprod Med. 2011;29:491–506.PubMed
10.
Management of Recurrent Early Pregnancy Loss. Washington, DC: The American College of Obstetricians and Gynecologists; 2001. The American College of Obstetricians and Gynecologists. (ACOG Practice Bulletin No. 24).
11.
Ali O, Hakimi I, Chanana A, et al. Grossesse sur utérus cloisonné menée à terme: à propos d’un cas avec revue de la literature. The Pan African Medical Journal. 2015;22:219.PubMedPubMedCentral
12.
Pluchino N, Drakopoulos P, Wenger JM, Petignat P, Streuli I, Genazzani AR. Hormonal causes of recurrent pregnancy loss (RPL). Hormones (Athens). 2014;13(3):314–22.
13.
Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103–11.
14.
Jovanovic L, Knopp H, Kim H, et al. Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancies: evidence for a protective adaptation in diabetes. Diabetes Care. 2005;28(5):1113–7.PubMed
15.
Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol. 2008;112(1):85–92.PubMedPubMedCentral
16.
Sarkar D. Recurrent pregnancy loss in patients with thyroid dysfunction. Indian Journal of Endocrinology and Metabolism. 2012;16(2):S350–1.PubMedPubMedCentral
17.
Shah D, Nagarajan N. Luteal insufficiency in first trimester. Indian Journal of Endocrinology and Metabolism. 2013;17(1):44–9.PubMedPubMedCentral
18.
Laurino MY, Bennett RL, Saraiya DS, Baumeister L, Doyle DL, Leppig K, et al. Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of genetic counselors. J Genet Couns. 2005;14(3):165–81.PubMed
19.
Stephenson MD, Sierra S. Reproductive outcomes in recurrent pregnancy loss associated with a parental carrier of a structural chromosome rearrangement. Hum Reprod. 2006;21(4):1076–82.PubMed
20.
Carp H, Guetta E, Dorf H, Soriano D, Barkai G, Schiff E. Embryonic karyotype in recurrent miscarriage with parental karyotypic aberrations. Fertil Steril. 2006;85(2):446–50.PubMed
21.
Benedetto C, Tibaldi C, Marozio L, Marini S, Masuelli G, Pelissetto S, et al. Cervicovaginal infections during pregnancy: epidemiological and microbiological aspects. J Matern Fetal Neonatal Med. 2004;16(2):9–12.PubMed
22.
Srinivas SK, Ma Y, Sammel MD, Chou D, McGrath C, Parry S, et al. Placental inflammation and viral infection are implicated in second trimester pregnancy loss. Am J Obstet Gynecol. 2006;195:797–802.PubMed
23.
Katz-Jaffe MG, Surrey ES, Minjarez DA, Gustofson RL, Stevens JM, Schoolcraft WB.
24.
Association of abnormal ovarian reserve parameters with a higher incidence of aneuploid blastocysts. Obstet Gynecol. 2013 ; 121(1):71–7.
25.
Matthews TJ, Hamilton BE. Delayed childbearing: more women are having their first child later in life. NCHS Data Brief. 2009;21:1–8.
26.
Nybo Anderson AM, Wohlfahrt J, Christens P, et al. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320:1708–12.
27.
Hassold T, Hall H, Hunt P. The origin of human aneuploidy: where we have been, where we are going. Hum Mol Genet. 2007;16:R203–8.PubMed
28.
Nagaoka SI, Hassold TJ, Hunt PA. Human aneuploidy: mechanisms and new insights into an age-old problem. Nat Rev Genet. 2012;13:493–504.PubMedPubMedCentral
29.
Quenby S, Vince G, Farquharson R, Aplin J. OPINION Recurrent miscarriage: A defect in nature's quality control? Hum Reprod. Aug. 2002;17(8):1959–63.
30.
Choi TY, Lee HM, Park WK, Jeong SY, Moon HS. Spontaneous abortion and recurrent miscarriage: a comparison of cytogenetic diagnosis in 250 cases. Obstet Gynecol Sci. 2014;57:518–25.PubMedPubMedCentral
31.
Kwinecka-Dmitriew B, Zakrzewska M, Latos-Bieleńska A, Skrzypczak J. Frequency of chromosomal aberrations in material from abortions. Ginekol Pol. 2010;81(12):896–901.PubMed
32.
Wang YA, Farquhar C, Sullivan EA. Donor age is a major determinant of success of oocyte donation/recipient programme. Hum Reprod. 2012;27(1):118–25.PubMed
33.
Sauer MV, Paulson RJ, Lobo RA. Pregnancy after age 50: application of oocyte donation to women after natural menopause. Lancet. 1993;341:321–3.PubMed
34.
Sauer MV, Paulson RJ, Lobo RA. Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation. Fertil Steril. 1995;64:111–5.PubMed
35.
Antinori S, Versaci C, Gholami GH, Panci C, Caffa B. Oocyte donation in menopausal women. Hum Reprod. 1993;8:1487–90.PubMed
36.
Check JH, Nowroozi K, Barnea ER, Shaw KJ, Sauer MV. Successful delivery after age 50: a report of two cases as a result of oocyte donation. Obstet Gynecol. 1993;81:835–6.PubMed
37.
Sills ES, Anthony MM, Walsh PH. Ovarian reserve screening in infertility: practical applications and theoretical directions for research. Eur J Obstet Gynecol Reprod Biol. 2009;146(1):30–6.PubMed
38.
May-Panloup P, Ferré-L'Hôtellier V, Morinière C, Marcaillou C, Lemerle S, Malinge MC, et al. Molecular characterization of corona radiata cells from patients with diminished ovarian reserve using microarray and microfluidic-based gene expression profiling. Hum Reprod. 2012;27(3):829–43.PubMed
39.
El Toukhy T, Khalaf Y, Hart R, Taylor A. Braude P; young age does not protect against the adverse effects of reduced ovarian reserve—an eight year study. Hum Reprod. 2002;17(6):1519–24.PubMed
40.
Maroulis GB. Effect of aging on fertility and pregnancy. Semin Reprod Endocrinol. 1991;9:165–75.
41.
Volarcik K, Sheean L, Goldfarb J, Woods L, Abdul-Karim FW, Hunt P. The meiotic competence of in-vitro matured human oocytes is influenced by donor age: evidence that folliculogenesis is compromised in the reproductively aged ovary. Hum Reprod. 1998;13:154–60.PubMed
42.
Delhanty JD. Mechanisms of aneuploidy induction in human oogenesis and early embryogenesis. Cytogenet Genome Res. 2005;111:237–44. 192PubMed
43.
Pellestor F, Andre’ OB, Anahory T, Hamamah S. The occurrence of aneuploidy in human: lessons from the cytogenetic studies of human oocytes. Eur J Med Genet. 2006;49:103–16. 193PubMed
44.
Tsutsumi M, Fujiwara R, Nishizawa H, Ito M, Kogo H, Inagaki H, et al. Agerelated decrease of meiotic cohesins in human oocytes. PLoS One. 2014;9:e96710.PubMedPubMedCentral
45.
Atasever M, Soyman Z, Demirel E, Gencdal S, Kelekci S. Diminished ovarian reserve: is it a neglected cause in the assessment of recurrent miscarriage? A cohort study. Fertil Steril. 2016;105(5):1236–40.PubMed
46.
Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod. 2008;23:699–708.PubMed
47.
48.
49.
Ottolenghi C, Uda M, Hamatani T, Crisponi L, Garcia JE, KoM PG, et al. Aging of oocyte, ovary, and human reproduction. Ann N Y Acad Sci. 2004;1034:117–31.PubMed
50.
Broekmans FJ, Knauff EA, te Velde ER, Macklon NS, Fauser BC. Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab. 2007;18:58–65.PubMed
51.
Chapman C, Cree L, Shelling AN. The genetics of premature ovarian failure: current perspectives. Int J Womens Health. 2015;7:799–810.PubMedPubMedCentral
52.
Qin Y, Jiao X, Simpson JL. Chen ZJ genetics of primary ovarian insufficiency: new developments and opportunities. Hum Reprod Update. 2015;21(6):787–808.PubMedPubMedCentral
53.
Hakim RB, Gray RH, Zacur H. Infertility and early pregnancy loss. Obstet Gynecol. 1995;172(5):1510–7.
54.
Coulam CB. Association between infertility and spontaneous abortion. Am J Reprod Immunol. 1992;27(3–4):128–9.PubMed
55.
Molo MW, Kelly M, Balos R, Mullaney K, Radwanska E. Incidence of fetal loss in infertility patients after detection of fetal heart activity with early transvaginal ultrasound. J Reprod Med. 1993;38(10):804–6.PubMed
56.
Liu HC, Rosenwaks Z. Early pregnancy wastage in IVF (in vitro fertilization) patients. J In Vitro Fert Embryo Transf. 1991;8(2):65–72.PubMed
57.
Cocksedge KA, Li TC, Saravelos SH, Metwally MA. Reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage. Reprod BioMed Online. 2008;17(1):151–60.PubMed
58.
Trogstad L, Magnus P, Moffett A, Stoltenberg C. The effect of recurrent miscarriage and infertility on the risk of pre-eclampsia. BJOG. 2009;116(1):108–13.PubMed
59.
Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604–6.PubMed
60.
Torrealday S, Kodaman P, Pal L. Premature Ovarian Insufficiency - an update on recent advances in understanding and management. F1000Research. 2017;6:2069.PubMedPubMedCentral
61.
Sato Y, Kawamura N, Kawamura K. Infertility Treatment in Primary Ovarian Insufficiency: Fertility Preservation and In Vitro Activation. J Gynecol Women’s Health. 2017; 7(1): JGWH.MS.ID.555704.
62.
Qin Y, Choi Y, Zhao H, Simpson JL, Chen ZJ, Rajkovic A. NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet. 2007;81(3):576–81.PubMedPubMedCentral
63.
Lourenço D, Brauner R, Lin L, De Perdigo A, Weryha G, et al. Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med. 2009;360(12):1200–10.PubMedPubMedCentral
64.
Rah H, Jeon YJ, Ko JJ, Kim JH, Kim YR, Cha SH, et al. Association of inhibin α gene promoter polymorphisms with risk of idiopathic primary ovarian insufficiency in Korean women. Maturitas. 2014;77(2):163–7.PubMed
65.
Chand AL, Ponnampalam AP, Harris SE, et al. Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure. Fertil Steril. 2006;86(4):1009–12.PubMed
66.
Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein- 15 (BMP15) gene. Am J Hum Genet. 2004;75(1):106–11.PubMedPubMedCentral
67.
Santos MG, Machado AZ, Martins CN, et al. Homozygous Inactivating Mutation in NANOS3 in Two Sisters with Primary Ovarian Insufficiency. Biomed Res Int. 2014;2014(787465):8.
68.
Wu X, Wang B, Dong Z, Zhou S, Liu Z, Shi G, et al. A NANOS3 mutation linked to protein degradation causes premature ovarian insufficiency. Cell Death Dis. 2013;4:e825.PubMedPubMedCentral
69.
Tucker EJ, Grover SR, Bachelot A, Touraine P, Sinclair AH. Premature ovarian insufficiency: new perspectives on genetic cause and phenotypic Spectrum. Endocr Rev. 2016;37(6):609–35.PubMed
70.
Fonseca DJ, Patiño LC, Suárez YC, et al. Next generation sequencing in women affected by nonsyndromic premature ovarian failure displays new potential causative genes and mutations. Fertil Steril. 2015;104(1):154–62. e2PubMed
71.
Aittomäki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995;82(6):959–68.PubMed
72.
Caburet S, Arboleda VA, Llano E, Overbeek PA, Barbero JL, Oka K, et al. Mutant cohesin in premature ovarian failure. N Engl J Med. 2014;370(10):943–9.PubMedPubMedCentral
73.
Takebayashi K, Takakura K, Wang H, Kimura F, et al. Mutation analysis of the growth differentiation factor-9 and −9B genes in patients with premature ovarian failure and polycystic ovary syndrome. Fertil Steril. 2000;74:976–9.PubMed
74.
Di Pasquale E, Rossetti R, Marozzi A, Bodega B, et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab. 2006;91(5):1976–9.PubMed
75.
Dixit H, Rao LK, Padmalatha V, Kanakavalli M, Deenadayal M, Gupta N, et al. Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause. 2005;12(6):749–54.PubMed
76.
Persani L, Rossetti R, Cacciatore C. Genes involved in human premature ovarian failure. J Mol Endocrinol. 2010;45(5):257–79.PubMed
77.
Tiotiu D, Alvaro Mercadal B, Imbert R, Verbist J, Demeestere I, de Leener A, et al. Variants of the BMP15 gene in a cohort of patients with premature ovarian failure. Hum Reprod. 2010;25(6):1581–7.PubMed
78.
Auclair S, Rossetti R, Meslin C, Monestier O, di Pasquale E, Pascal G, et al. Positive selection in bone morphogenetic protein 15 targets a natural mutation associated with primary ovarian insufficiency in human. PLoS One. 2013;8(10):e78199.PubMedPubMedCentral
79.
Ferrarini E, Russo L, Fruzzetti F, Agretti P, De Marco G, et al. Clinical characteristics and genetic analysis in women with premature ovarian insufficiency. Maturitas. 2013;74(1):61–7.PubMed
80.
Dixit H, Rao LK, Padmalatha VV, Kanakavalli M, et al. Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet. 2006;119(4):408–15.PubMed
81.
Laissue P, Christin-Maitre S, Touraine P, Kuttenn F, Ritvos O, Aittomaki K, et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol. 2006;154(5):739–44.PubMed
82.
Kovanci E, Rohozinski J, Simpson JL, Heard MJ, et al. Growth differentiating factor-9 mutations may be associated with premature ovarian failure. Fertil Steril. 2007;87(1):143–6.PubMed
83.
Wang TT, Ke ZH, Song Y, Chen LT, Chen XJ, Feng C, et al. Identification of a mutation in GDF9 as a novel cause of diminished ovarian reserve in young women. Hum Reprod. 2013;28(9):2473–81.PubMed
84.
Simpson CM, Robertson DM, Al-Musawi SL, Heath DA, et al. Aberrant GDF9 expression and activation are associated with common human ovarian disorders. J Clin Endocrinol Metab. 2014;99(4):E615–24.PubMed
85.
Gode F, Gulekli B, Dogan E, Korhan P, Dogan S, Bige O, et al. Influence of follicular fluid GDF9 and BMP15 on embryo quality. Fertil Steril. 2011;95(7):2274–8.PubMed
86.
Wu Y-T, Tang L, Cai J, Lu X-E, Xu J, Zhu X-M, et al. High bone morphogenetic protein-15 level in follicular fluid is associated with high quality oocyte and subsequent embryonic development. Hum Reprod. 2007;22(6):1526–31.PubMed
87.
Li Y, Li RQ, Ou SB, Zhang NF, Ren L, Wei LN, et al. Increased GDF9 and BMP15 mRNA levels in cumulus granulosa cells correlate with oocyte maturation, fertilization, and embryo quality in humans. Reprod Biol Endocrinol. 2014;12:81.PubMedPubMedCentral
88.
Lee MT, Bonneau AR, Giraldez AJ. Zygotic genome activation during the maternal-to-zygotic transition. Annu Rev Cell Dev Biol. 2014;30:581–613.PubMedPubMedCentral
89.
90.
Langley AR, Smith JC, Stemple DL, Harvey SA. New insights into the maternal to zygotic transition. Development. 2014;141:3834–41.PubMed
91.
Lu X, Gao Z, Qin D, Li L. A maternal functional module in the mammalian oocyte-to-embryo transition. Trends Mol Med. 2017;23(11):1014–23.PubMed
92.
Matzuk MM, Burns KH, Viveiros MM, Eppig JJ. Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science. 2002;296:2178–80.PubMed
93.
Bettegowda A, Lee KB, Smith GW. Cytoplasmic and nuclear determinants of the maternal-to-embryonic transition. Reprod Fertil Dev. 2008;20(1):45–53.PubMed
94.
Flach G, Johnson MH, Braude PR, Taylor RA, Bolton VN. The transition from maternal to embryonic control in the 2-cell mouse embryo. EMBO J. 1982;1:681–6.PubMedPubMedCentral
95.
96.
Huang JY, Su M, Lin SH, Kuo PL. A genetic association study of NLRP2 and NLRP7genes in idiopathic recurrent miscarriage. Hum Reprod. 2013;28(4):1127–34.PubMed
97.
Qian J, Nguyen NMP, Rezaei M, Huang B, Tao Y, Zhang XF, et al. Biallelic PADI6 variants linking infertility, miscarriages, and hydatidiform moles. Eur J Hum Genet. 2018;26(7):1007–13.PubMed
98.
Fogarty NME, McCarthy A, Snijders KE, Powell BE, Kubikova N, Blakeley P, et al. Genome editing reveals a role for OCT4 in human embryogenesis. Nature. 2017;550(7674):67–73.PubMedPubMedCentral
99.
Zhang P, Dixon M, Zucchelli M, Hambiliki F, Levkov L, Hovatta O, et al. Expression analysis of the NLRP gene family suggests a role in human preimplantation development. PLoS One. 2008;3(7):e2755.PubMedPubMedCentral
100.
Li L, Baibakov B, Dean J. A subcortical maternal complex essential for preimplantation mouse embryogenesis. Dev Cell. 2008;15(3):416–25.PubMedPubMedCentral
101.
Zhu K, Yan L, Zhang X, Lu X, Wang T, Yan J, et al. Identification of a human subcortical maternal complex. Mol Hum Reprod. 2015;21(4):320–9.PubMed
102.
103.
Joshi S, Davies H, Sims LP, Levy SE, Dean J. Ovarian gene expression in the absence of FIGLA, an oocyte-specific transcription factor. BMC Dev Biol. 2007;7:67.PubMedPubMedCentral
104.
Choi Y, Qin Y, Berger M, Ballow D, et al. Microarray analyses of newborn mouse ovaries lacking Nobox. Biol Reprod. 2007;77(2):312–9.PubMed
105.
Choi Y, Rajkovic A. Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters. J Biol Chem. 2006;281(47):35747–56.PubMed
106.
Tsuda M, Sasaoka Y, Kiso M, Abe K, Haraguchi S, Kobayashi S, et al. Conserved role of nanos proteins in germ cell development. Science. 2003;301:1239–41.PubMed
107.
Stephanie A. Pangas, Aleksandar Rajkovic; transcriptional regulation of early oogenesis: in search of masters. Hum Reprod Update. 2006;12(1):65–76.
108.
Rajkovic A, Pangas SA, Ballow D, Suzumori N, Matzuk MM. NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science. 2004;305:1157–9.PubMed
109.
Tripurani SK, Lee K-B, Wang L, Wee G, Smith GW, Lee YS, et al. A novel functional role for the oocyte-specific transcription factor newborn ovary Homeobox (NOBOX) during early embryonic development in cattle. Endocrinology. 2011;152(3):1013–23.PubMed
110.
111.
112.
113.
Bouilly J, Beau I, Barraud S, Bernard V, Azibi K, Fagart J, et al. Identification of multiple gene mutations accounts for a new genetic architecture of primary ovarian insufficiency. J Clin Endocrinol Metab. 2016;101(12):4541–50.PubMed
114.
Zhao S, Li G, Dalgleish R, Vujovic S, Jiao X, Li J, et al. Transcription factor SOHLH1 potentially associated with primary ovarian insufficiency. Fertil Steril. 2015;103(2):548–53. e5PubMed
115.
Qin Y, Jiao X, Dalgleish R, Vujovic S, Li J, et al. Novel variants in the SOHLH2 gene are implicated in human premature ovarian failure. Fertil Steril. 2014;101(4):1104–9. e6PubMed
116.
Ferrari I, Bouilly J, Beau I, Guizzardi F, Ferlin A, Pollazzon M, et al. Impaired protein stability and nuclear localization of NOBOX variants associated with premature ovarian insufficiency. Hum Mol Genet. 2016;25(23):5223–33.PubMed
117.
Li L, Wang B, Zhang W, Chen B, Luo M, Wang J, et al. A homozygous NOBOX truncating variant causes defective transcriptional activation and leads to primary ovarian insufficiency. Hum Reprod. 2017;32(1):248–55.PubMed
118.
Jiao X, Qin Y, Li G et al. Novel NR5A1 Missense Mutation in Premature Ovarian Failure: Detection in Han Chinese Indicates Causation in Different Ethnic Groups. Sun Q-Y, ed. PLoS ONE. 2013; 8(9):e74759.
119.
Tosh D, Rani HS, Murty US, Deenadayal A, Grover P. Mutational analysis of the FIGLA gene in women with idiopathic premature ovarian failure. Menopause. 2015;22(5):520–6.PubMed
120.
Liu L, Rajareddy S, Reddy P, du C, Jagarlamudi K, Shen Y, et al. Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a. Development. 2007;134:199–209.PubMed
121.
Cunningham MA, Zhu Q, Hammond JM. FoxO1a can alter cell cycle progression by regulating the nuclear localization of p27kip in granulosa cells. Mol Endocrinol. 2004;18:1756–67.PubMed
122.
Vinci G, Christin-Maitre S, Pasquier M, et al. FOXO3a variants in patients with premature ovarian failure. Clin Endocrinol. 2008;68:495–7.
123.
Watkins WJ, Umbers AJ, Woad KJ, Harris SE, et al. Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure. Fertil Steril. 2006;5:1518–21.
124.
Pisarska MD, Bae J, Klein C, Aaron J, Hsueh W. Forkhead L2 Is Expressed in the Ovary and Represses the Promoter Activity of the Steroidogenic Acute Regulatory Gene. Endocrinology. 2004;145(7):3424–33.PubMed
125.
Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet. 2001;27:159–66.PubMed
126.
Méduri G, Bachelot A, Duflos C, et al. FOXL2 mutations lead to different ovarian phenotypes in BPES patients: case report. Hum Reprod. 2010;25:235–43.PubMed
127.
Nallathambi J, Moumné L, De Baere E, et al. A novel polyalanine expansion in FOXL2: the first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction. Hum Genet. 2007;121:107–12.PubMed
128.
Harris SE, Chand AL, Winship IM, Gersak K, Aittomäki K, Shelling AN. Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod. 2002;8(8):729–33.PubMed
129.
Laissue P, Lakhal B, Benayoun BA, Dipietromaria A, Braham R, Elghezal H, et al. Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2. J Med Genet. 2009;46:455–7.PubMed
130.
Salker M, Teklenburg G, Molokhia M et al. Natural Selection of Human Embryos: Impaired Decidualization of Endometrium Disables Embryo-Maternal Interactions and Causes Recurrent Pregnancy Loss. Vitzthum VJ, ed. PLoS ONE. 2010; 5(4):e10287.
131.
Salker MS, Christian M, Steel JH, Nautiyal J, Lavery S, Trew G, et al. Deregulation of the serum- and glucocorticoid-inducible kinase SGK1 in the endometrium causes reproductive failure. Nat Med. 2011;17:1509–13.PubMed
132.
Salker MS, Nautiyal J, Steel JH, Webster Z, Šućurović S, Nicou M, et al. Disordered IL-33/ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy. PLoS One. 2012;7(12):e52252.PubMedPubMedCentral
133.
Lucas ES, Dyer NP, Murakami K, Hou Lee Y, Chan YW, Grimaldi G, et al. Loss of endometrial plasticity in recurrent pregnancy loss. Stem Cells. 2016;34:346–56.PubMed
134.
Christian M, Zhang X, Schneider-Merck T, Unterman TG, Gellersen B, White JO, et al. Cyclic AMP-induced forkhead transcription factor, FKHR, cooperates with CCAAT/enhancer-binding protein β in differentiating human endometrial stromal cells. J Biol Chem. 2002;277:20825–32.PubMed
135.
Labied S, Kajihara T, Madureira PA, Fusi L, Jones MC, Higham JM, et al. Progestins regulate the expression and activity of the Forkhead transcription factor FOXO1 in differentiating human endometrium. Mol Endocrinol. 2006;20(1):35–44.PubMed
136.
Kajihara T, Jones M, Fusi L, Takano M, Feroze-Zaidi F, Pirianov G, et al. Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization. Mol Endocrinol. 2006;20(10):2444–55.PubMed
137.
Kajihara T, Brosens JJ, Ishihara O. The role of FOXO1 in the decidual transformation of the endometrium and early pregnancy. Med Mol Morphol. 2013;46(2):61–8.PubMed
138.
Bellessort B, Bachelot A, Heude É, Alfama G, Fontaine A, Le Cardinal M, et al. Role of Foxl2 in uterine maturation and function. Hum Mol Genet. 2015;24(11):3092–103.PubMed
139.
Governini L, Carrarelli P, Rocha AL, Leo VD, Luddi A, Arcuri F, et al. FOXL2 in human endometrium: Hyperexpressed in endometriosis. Reprod Sci. 2014;21(10):1249–55.PubMed
140.
Eozenou C, Vitorino Carvalho A, Forde N, Giraud-Delville C, Gall L, Lonergan P, et al. FOXL2 is regulated during the bovine estrous cycle and its expression in the endometrium is independent of conceptus-derived interferon tau. Biol Reprod. 2012;87(2):32.PubMed
141.
Popovici RM, Betzler NK, Krause MS, Luo M, Jauckus J, Germeyer A, et al. Gene expression profiling of human endometrial-trophoblast interaction in a coculture model. Endocrinology. 2006;147(12):5662–75.PubMed
142.
Elbaz M, Hadas R, Bilezikjian LM, Gershon E. Uterine Foxl2 regulates the adherence of the Trophectoderm cells to the endometrial epithelium. Reprod Biol Endocrinol. 2018;16:12.PubMedPubMedCentral
Metadaten
Titel
Connecting links between genetic factors defining ovarian reserve and recurrent miscarriages
verfasst von
Deepika Delsa Dean
Sarita Agarwal
Poonam Tripathi
Publikationsdatum
15.09.2018
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 12/2018
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-018-1305-3

Weitere Artikel der Ausgabe 12/2018

Journal of Assisted Reproduction and Genetics 12/2018 Zur Ausgabe

Assisted Reproduction Technologies

In vitro maturation (IVM) of oocytes in patients with resistant ovary syndrome and in patients with repeated deficient oocyte maturation

Editor’s Commentary

Bringing perspective to the next wave of human ARTs

Commentary

Monozygotic twinning in the IVF era: is it time to change existing concepts?

Assisted Reproduction Technologies

Concentration of soluble urokinase plasminogen activator receptor (suPAR) in the pre-ovulatory follicular fluid is associated with development of ovarian hyperstimulation syndrome during ovarian stimulation

Commentary

The use of a virtual journal club to promote cross-cultural learning in the reproductive sciences

Assisted Reproduction Technologies

Ibuprofen does not have an adverse impact on semen parameters

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise